藥物成份

共有 21645 個藥物成份

Calcium Carbonate contains not less than 98.5% and not more than 101.0% of CaCO3, calculated on the dried basis.

• 關聯藥證數量: 1

Calcium Carbonate, contains calcium equivalent to not less than 98.0% and not more than 100.5% of CaCO3.

• 關聯藥證數量: 1

Calcium Carbonate, contains calcium equivalent to not less than 98.5% and not more than 100.5% of CaCO3, calculated on the dried basis.

• 關聯藥證數量: 1

Calcium Chloride 0.025 M.

• 關聯藥證數量: 1

Calcium Chloride-2-Hydrate contains not less than 99.0% and not more than 103.0% of CaCl2‧2H2O

• 關聯藥證數量: 1

Calcium Folinate (Leucovorin Calcium) contains not less than 97.0% and not more than 102.0% of C20H21CaN7O7, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Calcium Folinate contains not less than 97.0% and not more than 102.0% of C20H21CaN7O7, and contains 7.54% to 8.14% of Calcium, both calculated on anhydrous substance.

• 關聯藥證數量: 1

Calcium Folinate contains not less than 97.0% and not more than 102.0% of C20H21CaN7O7, calculated on anhydrous substance.

• 關聯藥證數量: 1

Calcium Folinate contains not less than 97.0% and not more than the equivalent of 102.0% of calcium (2S)-2-{[4-[[[(6RS)-2-amino-5-formy-4-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl]amino]benzoyl]amino} pentanedioate and not less than 7.54 percent and not more than the equivalent of 8.14 percent of Ca, both calculated with reference to the anhydrous and solvent-free substance.

• 關聯藥證數量: 1

Calcium HRII:1. Buffer Monoethanolamine buffer 0.88 mol/L (pH 11.0)2. Color OCPC 0.1 mmol/L Quinolinol (8-Hydroxyquinoline) 11 mmol/LCalcium E-HA:1. Buffer 3.3 mol/L Monoethanolamin buffer, PH 12.02. Color appearance testingMXB 0.29 mmol/L8-Quinolinol 31 mmol/L

• 關聯藥證數量: 1

Calcium Hydroxylapatite(75-125 microns) ..............30%\nSterile Water for Injection, U.S.P. .........................52%\nGlycerin, U.S.P. .................................................15%\nSodium Carboxymethylcellulose, U.S.P. .................3%

• 關聯藥證數量: 1

Calcium Polystyrene Sulfonate (eq. to Calcium polystyrene sulphonate), C8H7CaO3S+, is a cation-exchange resin prepared in the calcium form containing not less than 6.5% w/w and not more than 9.5% w/w of calcium, calculated with reference to the dried substance. Each g exchanges not less than 1.3 mEq and not more than 2.0mEq of potassium, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Calcium Sennoside 90TPC contains not less than 90.0% and not more than 110.0% of C42H36O20Ca.

• 關聯藥證數量: 1

Calcium Sennosides 60TPC contains not less than 60.0% of C42H36O20Ca, calculated on the dried basis.

• 關聯藥證數量: 1

Calcium acetate contains assay (titration) 99.0%~100.5% (on Anhydrous basis)

• 關聯藥證數量: 1

Calcium carbonate 25mg/L; Potassium dihydrogenphosphate 176mg/L; Magnesium nitrate 0.012mmol/L; Iron(II) ammonium sulfate hexahydrate 35.2mg/L; Glucose 2.0g/L; Creatinine 30mg/L; Preservative in suitable quantity.

• 關聯藥證數量: 1

Calcium chloride dihydrate contains less than 97.0% and not more than 103.0% of CaCl2．2H2O

• 關聯藥證數量: 1

Calcium chloride dihydrate contains not less than 97.0% and not more than 103.0% of CaCl2‧2H2O.

• 關聯藥證數量: 1

Calcium hydroxide.....34%\nPhosphoric acid.....13.8%\nWater.....82.8%\n以下空白

• 關聯藥證數量: 1

Calcium-D-Pantothenate contains not less than 98.0% and not more than 101.0% of C18H32CaN2O10, calculated on dried basis.

• 關聯藥證數量: 1

Calibration plasma：10 X 1ml vials of lyophilized human plasma containing buffer.

• 關聯藥證數量: 1

Calibrator #1：0.20% w/v potassium phosphate monobasic; 0.18% w/v sodium chloride; 0.10% w/v sodium acetate; 0.80% w/v urea; with preservative.\nCalibrator #2：2.00% w/v potassium phosphate monobasic; 0.18% w/v sodium chloride; 1.00% w/v sodium acetate; 8.00% w/v urea; with preservative.\nCalibrator #3：0.50% w/v potassium phosphate monobasic; 0.45% w/v sodium chloride; 0.25% w/v sodium acetate; 2.00% w/v urea; 2.00% w/v glucose; 0.50% w/v bovine albumin; with preservative.\nCalibrator #4：0.01% w/v polymer beads; with surfactant and 0.05% w/v sodium azide as preservative\n

• 關聯藥證數量: 1

Calibrator 0: lyophilized reagent, ACTH-free human plasma.\nACTH Calibrators (A-E): lyophilized reagent, ACTH calibrators (porcine), at nominal concentrations ranging from 20-500 pg/mL (4.5-112 picomoles/L).\nACTH Antiserum: lyophilized reagent, Rabbit anti-ACTH serum diluted in BSA-borate buffer with Thimerosal.\nI-125 ACTH: lyophilized reagent, Synthetic ACTH labeled with iodine-125, diluted in BSA-borated-EDTA buffer with Thimerosal.\nPrecipitating Complex (GAR-PPT): lyophilized reagent, Normal rabbit serum, pre-precipitated with goat anti-rabbit serum and polyethylene glycol (PEG), is diluted in BSA-borate buffer with Thimerosal.\nACTH Control (Level 1 and 2): lyophilized reagent, Human plasma spiked, if necessary, with the appropriate amount of synthetic ACTH to obtain a concentrate within a specified range.

• 關聯藥證數量: 1

Calibrator 1：(5 μg/mL) 2mL x 1\nCalibrator 2：(25 μg/mL) 2mL x 1\nCalibrator 3 ：(100 μg/mL) 2mL x 1\nCalibrator 4 ：(300 μg/mL) 2mL x 1\nCalibrator 5 ：(500 μg/mL) 2mL x 1

• 關聯藥證數量: 1

Calibrator 1：0.20 % w/v potassium phosphate monobasic, 0.18% w/v sodium chloride, 0.10% w/v sodium acetate, 0.80% w/v urea, preservative

• 關聯藥證數量: 1

Calibrator 2：2.00 % w/v potassium phosphate monobasic, 1.80% w/v sodium chloride, 1.00% w/v sodium acetate, 8.00% w/v urea, preservative

• 關聯藥證數量: 1

Calibrator 3：0.50 % w/v potassium phosphate monobasic, 0.45% w/v sodium chloride, 0.25% w/v sodium acetate, 2.00% w/v urea, 2.00% w/v glucose, 0.50% w/v bovine albumin, preservative

• 關聯藥證數量: 1

Calibrator 4：0.01% w/v polymer beads, surfactant, 0.05% w/v sodium azide

• 關聯藥證數量: 1

Calibrator A Sodium Chloride 150mM 1x1ml\n Sodium Azide 0.1%\nCalibrator B-F Human Serum 5x1ml\n Sodium Azide 0.1%

• 關聯藥證數量: 1

Calibrator A：150mM Sodium Chloride 1x1 ml\nCalibrator B-F Human Prealbumin 5x1 ml\n150mM Sodium Chloride

• 關聯藥證數量: 1

Calibrator Kit 19 are prepared from lyophilized human serum.\nFS Calibrator 1 is prepared from sodium chloride (154mM) and processed water.\nFS Reconstitution Diluent is prepared from processed water.

• 關聯藥證數量: 1

Calibrator Low (lyophilized), for 3mL in vial 2 vials (Box A)\nCalibrator High (lyophilized), for 3mL in vial 2 vials (Box A)\nDistilled water, 20 mL in vial 2 vials (Box B)\nCalibration Card 1 card (Box B)\n

• 關聯藥證數量: 1

Calibrator kit 27：aqueous solution containing amino acids and inorganic acid.

• 關聯藥證數量: 1

Calibrator serum : \nSolution containing human anti-mannan antibodies derived from a serum tested negative for anti-HIV1 and anti-HIV2 antibodies, HBs antigen and anti-HCV antibody, used for preparation of the range points.\nPreservative: < 0.1% sodium azide.

• 關聯藥證數量: 1

Calibrator, control: sheep blood with dithiothreitol(PTT). \nSubstrate reagent:β-NADP, glucose-6-phosphate and sucrose. \nReconstitutionl buffer:Tris-HCl, magnesium chloride.\nCopper reagent: sodium carbonate, potassium sodium tartrate and <0.05% cupric sulfate.

• 關聯藥證數量: 1

Calibrator: 5 vial, 2.0 mL/vial containing Human serum albumin in buffered solution, Sodium azide(0.09%).

• 關聯藥證數量: 1

Calibrators (human) 6×1.5 mlPositive Control (human) 1.5 mlNegative Control (human) 1.5 mlWash Buffer Concentrate (20x) 75 mlSample Diluent 100 mlConjugate, anti-h-IgG-HRP (Horseradish Peroxidase) 20 mlSubstrate TMB 20 mlStop Solution, Sulfuric Acid 0.5 M) 20 mlMicroplate Strips, 12×8 wells

• 關聯藥證數量: 1

Calibrators 6 vials, 1.5 ml each 0, 3, 10, 30, 100, 300 GPL/ml or MPL/ml.\n(color increasing with concentration: yellow solution)\nContaining: Human serum (diluted), sodium azide < 0.1 % (preservative)\nConjugated 1 vial, 15 ml IgG (capped blue: blue solution)\n1 vial, 15 ml IgM (capped green: green solution)\nContaining: Anti-human immunglobulins conjugated to horseradish perxidase\nTMB Substrate 1 vial, 15 ml (capped black)\nContaining: Stabilized TMB/H2O2\nStop Soluiton 1 vial, 15 ml (capped white: colorless solution)\nContaining: 1M Hydrochloric Acid\nMicrotiterplate 12x8 well strips with breakaway microwells

• 關聯藥證數量: 1

Calibrators : 20ng/ml、50ng/ml、100ng/ml，and 200 ng/ml 11-nor-△9-THC-COOH in human urine.\nControls : 40 ng/ml、60ng/ml、75ng/ml，and 125 ng/ml 11-nor-△9-THC-COOH in human urine.

• 關聯藥證數量: 1

Calibrators A-F (each 2.5 mL), 0, 2.5, 5.0, 10.0, 20.0, 40.0 μg/mL.

• 關聯藥證數量: 1

Calibrators are prepared from bovine serum albumin to which human heart tissue CKMB, inorganic salts, stabilizers and preservatives have been added. The concentrations (U/L) for calibrator 1, 2 and 4 are 5, 50 and 275.

• 關聯藥證數量: 1

Calibrators are prepared from processed human serum to which cholinesterase (CHE) from equine serum, lithium chloride (Li), theophylline (THEO), electrolytes, organic analytes, stabilizers and preservatives have been added.\nThe calibrator values used for CHE, Li and THEO of Calibrator 1-2-4 are \nCHE (U/mL): 0.00-5.00-12.30\nLi (mmol/L): 0.2-1.5-4.0\nTHEO (μg/mL): 1.5-10.0-35.0 \n

• 關聯藥證數量: 1

Calibrators: The exact lot-specific calibrator values are encoded in the barcoded labels of the test-specific reagent.

• 關聯藥證數量: 1

Calmagite (Dye Reagent) 0.15 mmol/L\nAlkaline Solution (pH>13.0)

• 關聯藥證數量: 1

Canagliflozin Hemihydrate contains not less than 98.0% and not more than 102.0% of C24H25FO5S‧1/2H2O, calculated on the dried substance.

• 關聯藥證數量: 1

Canagliflozin Hydrate

• 關聯藥證數量: 1

Canakinumab

• 關聯藥證數量: 1

Candesartan Cilexetil Assay (Anhydrous substance)：99.0-101.0%

• 關聯藥證數量: 1

Candesartan Cilexetil contains not less than 99.0% and not more than 101.0% of C33H34N6O6, calculated on anhydrous substance.

• 關聯藥證數量: 1

Candesartan Cilexetil contains not less than 99.0% and not more than 101.0% of C33H34N6O6, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Candesartan Cilexetil contains not less than 99.0% and not more than 101.0% of C33H34N6O6, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Candesartan Cilexetil contains：99.0 % to 101.0% (anhydrous substance.)

• 關聯藥證數量: 1

Cannabidiol Assay (HPLC, wt%): 97.0%~103.0%

• 關聯藥證數量: 1

Cannabinoids

• 關聯藥證數量: 1

Capecitabine contains not less than 98.0 percent and not more than than 102.0 percent of C15H22FN3O6 calculated on the anhydrous and solvent free basis.

• 關聯藥證數量: 1

Capillaries for Glukometer 3000: Polyvinyl chloride (PVC) compounded\nFluid bag for Glukometer 3000: water saline solution.\ncontrol L1: water saline solution containing 5.8 mmol/L D-glucose\ncontrol L2: water saline solution containing 13.0 mmol/L D-glucose\ncalibrator: water saline solution containing 5 mmol/L D-glucose

• 關聯藥證數量: 1

Capso-buffered Saline...........10L

• 關聯藥證數量: 1

Captopril contains not less than 97.5 percent and not more than 102.0 percent of C9H15NO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Captopril contains not less than 97.5% and not more than 102.0% of C9H15NO3S, Calculated on the dried basis.

• 關聯藥證數量: 1

Captopril contains not less than 97.5% and not more than 102.0% of C9H15NO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Captopril contains not less than 97.5% and not more than 102.0% of C9H15NO3S,Calculated on the dried basis.

• 關聯藥證數量: 1

Capture-R Ready-ID consisting 2x8 strips carrying the bound and dried membranes prepared from 13 group O donors, also contains two wells with dried red blood cell monolayer specifically to be used to test Capture-R Control Sera.\nCapture-R Ready-ID Extend consisting of 2x8 strips carrying the bound and dried membranes prepared form 14 group O donors, also contains two wells with dried red blood cell monolayer specifically to be used to test Capture-R Control Sera.

• 關聯藥證數量: 1

Capture-R Ready-Screen(3) consisting of 1x8 strips of wells carrying the bound and dried red blood cell membranes of three different group O donors, respectively (and a fourth positive control well coated with IgG sensitized red blood cell membranes).

• 關聯藥證數量: 1

Capture-R Select Microwell Strips：\nStrips of wells coated with an affinity isolated goat anti-murine antibody and an anti-RBC antibody to immobilize red blood cells to the microwell surface.\nCapture-R Ready Indicator Red Cells：\nanti-IgG coated human red blood cells.

• 關聯藥證數量: 1

Carbamazepine contains 98.0 per cent to 102.0 per cent of C15H12N2O (anhydrous substance).

• 關聯藥證數量: 1

Carbamazepine contains not less than 98.0% and not more than 102.0% of C15H12N2O, calculated on the dried basis.

• 關聯藥證數量: 1

Carbamazepine contains not less than 98.0% and not more than 102.0% of C15H12N2O, calculated on the dried basis.

• 關聯藥證數量: 1

Carbetapentane Citrate contains not less than 98% and not more than 100.5% of C20H31NO3 C6H8O7, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Carbidopa contains not less than 98.5% and not more than 101.0% of C10H14N2O4‧H2O, calculated on dried basis.

• 關聯藥證數量: 1

Carbidopa contains not less than 98.5% and not more than 101.0% of C10H14N2O4‧H2O, calculated on the dried basis.

• 關聯藥證數量: 1

Carbidopa contains not less than 98.5% and not more than 101.0% of C10H14N2O4‧H2O, calculated on the dried substance.

• 關聯藥證數量: 1

Carbimazole C7H10N2O2S 186.2 Ethyl 3-methyl-2-thioxo-2, 3-dihydro-1H-imidazole-1-carboxylate. Content：98.0 percent to 102.0 percent (dried substance).

• 關聯藥證數量: 1

Carbimazole contains not less than 98.0% and not more than 102.0% of C7H10N2O2S, calculated on the dried substance.

• 關聯藥證數量: 1

Carbocisteine contains not less than 98.5 per cent and not more than the equivalent of 101.0 per cent of (2R)-2-amino-3-[(carboxymethyl)sulfanyl]propanoic acid, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Carbocisteine contains not less than 98.5% and not more than 101.0% of C5H9NO4S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Carbocisteine contains not less than 98.5% and not more than 101.0% of the labeled amount of C5H9NO4S.

• 關聯藥證數量: 1

Carbocisteine contains not less than 98.5% and not more than the equivalent of 101.0% of C5H9NO4S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Carbocisteine(carbocysteine) contains not less than 98.5 per cent and not more than the equivalent of 101.0 per cent of (2R)-2-amino-3-[(carboxymethyl)sulfanyl]propanoic acid, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Carbolfuchsin、acid alcohol、Methylene blue

• 關聯藥證數量: 1

Carbolfuchsin：3% Fuchsin, 6% Phenol\nAcid Alcohol：3% HCL in 95% Ethanol solution\nCounterstain：0.5% Methylene Blue

• 關聯藥證數量: 1

Carbon Antigen-0.003% Cardiolipin, 0.020-0.022% Lecithin, 0.09% Cholesterol, Charcoal (activated) as visual enhancer, Phosphate buffer, Thimerosal preservative, stabilizers.\nControls (Reactive, Weak Reactive, Nonreactive)-Human serum of defibrinated plasma (liquid), with 0.1% Sodium Azide as preservative.

• 關聯藥證數量: 1

Carbon Dioxide (CO2) contains not less than 99.0% (v/v)

• 關聯藥證數量: 1

Carbon Dioxide (CO2) contains not less than 99.0% (v/v).

• 關聯藥證數量: 1

Carbon Dioxide (CO2) contains not less than 99.0%(v/v)

• 關聯藥證數量: 1

Carbon Dioxide (CO2) contains not less than 99.5% (v/v)

• 關聯藥證數量: 1

Carbon Dioxide contains not less than than 99.0% by volum of CO2

• 關聯藥證數量: 1

Carboplatin contains not less than 98.0% and not more than 102.0% of C6H12N2O4Pt, calculated on dried substance.

• 關聯藥證數量: 1

Carboprost tromethamine, 95.0-105.0%(anhydrous substance)

• 關聯藥證數量: 1

Carboxymethyl

• 關聯藥證數量: 1

Cardiac Pipettes 20 x 150 μl

• 關聯藥證數量: 1

Cardiac proBNP: One test strip contains biotinylated polyclonal anti-NT-proBNP antibodies >0.4 μg, gold-labelled monoclonal anti-NT-proBNP antibodies >0.1 μg, buffer and non-reactive components > 2.0 mg\nCardiac control proBNP: 1 x bottle 1 with lyophilizate for 1 ml of control serum, 1 x bottle 2 with lyophilizate for 1 ml of control serum; active ingredient: synthetic NT-proBNP (1-76).\n

• 關聯藥證數量: 1

Cardio ProfilER: Murine monoclonal and polyclonal antibodies against CK-MB, murine monoclonal and polyclonal antibodies against myoglobin, murine monoclonal and goat polyclonal antibodies against troponin I, and murine monoclonal and polyclonal antibodies against BNP labeled with a fluorescent dye and immobilized on the solid phase, and stabilizer.\nCardio ProfilER Controls: Buffered human plasma protein matrix containing <0.1% sodium azide, and CK-MB, Troponin-I, Myoglobin, and B-Type Natriuretic Peptide (BNP).\nCardio ProfilER Calibration Verification Controls: Buffered human plasma protein matrix containing <0.1% sodium azide, and CK-MB, Troponon-I, Myoglobin, and B-Type Natriuretic Peptide (BNP).\n

• 關聯藥證數量: 1

CardioImmune is a liquid stable control material prepared from human serum. Analyte levels are adjusted with various pure chemicals and preparations from human tissue or body fluids. Preservatives and stabilizers are added to maintain product integrity.

• 關聯藥證數量: 1

Cardiolipin IgM Well: coated with bovine cardiolipin antigen and bovine β2-glycoprotein l as co-factor.

• 關聯藥證數量: 1

Cardiolipin Well: coated with bovine cardiolipin antigen and bovine β2-glycoprotein l as co-factor.

• 關聯藥證數量: 1

Carglumic acid

• 關聯藥證數量: 1

Carisoprodol contains not less than 98% and not more than 102.0% of C12H24N2O4, calculated on the dried basis.

• 關聯藥證數量: 1

Carisoprodol contains not less than 98.0% and not more than 102.0% of C12H24N2O4 on dried basis.

• 關聯藥證數量: 1

Carrot

• 關聯藥證數量: 1

Carteolol Hydrochloride contains NLT 99.0% and NMT 101.0% of Carteolol Hydrochloride (C16H24N2O3‧HCl), calculated on the dried basis.

• 關聯藥證數量: 1